Cargando…
SARS-CoV2 entry factors are expressed in primary human glioblastoma and recapitulated in cerebral organoid models
PURPOSE: Glioblastoma (GBM) is the most common and malignant primary brain tumor in adults with a median overall survival of only 14.6 months despite aggressive treatment. While immunotherapy has been successful in other cancers, its benefit has been proven elusive in GBM, mainly due to a markedly i...
Autores principales: | Suarez-Meade, Paola, Watanabe, Fumihiro, Ruiz-Garcia, Henry, Rafferty, Seamus B., Moniz-Garcia, Diogo, Schiapparelli, Paula V., Jentoft, Mark E., Imitola, Jaime, Quinones-Hinojosa, Alfredo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9808689/ https://www.ncbi.nlm.nih.gov/pubmed/36595192 http://dx.doi.org/10.1007/s11060-022-04205-2 |
Ejemplares similares
-
Melatonin Treatment Triggers Metabolic and Intracellular pH Imbalance in Glioblastoma
por: Fernandez-Gil, Beatriz I., et al.
Publicado: (2022) -
DDRE-33. MELATONIN AS A MASTER METABOLIC SWITCH FOR GLIOBLASTOMA
por: Fernandez-Gil, Beatriz Irene, et al.
Publicado: (2021) -
Spatial transcriptomics in glioblastoma: is knowing the right zip code the key to the next therapeutic breakthrough?
por: Shireman, Jack M., et al.
Publicado: (2023) -
Regulation of Glioblastoma Tumor-Propagating Cells by the Integrin Partner Tetraspanin CD151()()
por: Tilghman, Jessica, et al.
Publicado: (2016) -
The endosomal pH regulator NHE9 is a driver of stemness in glioblastoma
por: Ko, Myungjun, et al.
Publicado: (2022)